261 related articles for article (PubMed ID: 11077440)
1. Expression of Brca1 and splice variant Brca1delta11 RNA levels in mouse mammary gland during normal development and tumorigenesis.
Mixon M; Kittrell F; Medina D
Oncogene; 2000 Nov; 19(46):5237-43. PubMed ID: 11077440
[TBL] [Abstract][Full Text] [Related]
2. Retroviral transduction of splice variant Brca1-Delta11 or mutant Brca1-W1777Stop causes mouse epithelial mammary atypical duct hyperplasia.
Bachelier R; Vincent A; Mathevet P; Magdinier F; Lenoir GM; Frappart L
Virchows Arch; 2002 Mar; 440(3):261-6. PubMed ID: 11889595
[TBL] [Abstract][Full Text] [Related]
3. Annexin A8 is up-regulated during mouse mammary gland involution and predicts poor survival in breast cancer.
Stein T; Price KN; Morris JS; Heath VJ; Ferrier RK; Bell AK; Pringle MA; Villadsen R; Petersen OW; Sauter G; Bryson G; Mallon EA; Gusterson BA
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6872-9. PubMed ID: 16203777
[TBL] [Abstract][Full Text] [Related]
4. The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues.
Marquis ST; Rajan JV; Wynshaw-Boris A; Xu J; Yin GY; Abel KJ; Weber BL; Chodosh LA
Nat Genet; 1995 Sep; 11(1):17-26. PubMed ID: 7550308
[TBL] [Abstract][Full Text] [Related]
5. Identification and functional analysis of novel BRCA1 transcripts, including mouse Brca1-Iris and human pseudo-BRCA1.
Pettigrew CA; French JD; Saunus JM; Edwards SL; Sauer AV; Smart CE; Lundström T; Wiesner C; Spurdle AB; Rothnagel JA; Brown MA
Breast Cancer Res Treat; 2010 Jan; 119(1):239-47. PubMed ID: 19067158
[TBL] [Abstract][Full Text] [Related]
6. Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues.
Rajan JV; Marquis ST; Gardner HP; Chodosh LA
Dev Biol; 1997 Apr; 184(2):385-401. PubMed ID: 9133444
[TBL] [Abstract][Full Text] [Related]
7. Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis.
Xu X; Qiao W; Linke SP; Cao L; Li WM; Furth PA; Harris CC; Deng CX
Nat Genet; 2001 Jul; 28(3):266-71. PubMed ID: 11431698
[TBL] [Abstract][Full Text] [Related]
8. BRCA1 expression during prenatal development of the human mammary gland.
Magdinier F; Dalla Venezia N; Lenoir GM; Frappart L; Dante R
Oncogene; 1999 Jul; 18(27):4039-43. PubMed ID: 10435628
[TBL] [Abstract][Full Text] [Related]
9. The caM kinase, Pnck, is spatially and temporally regulated during murine mammary gland development and may identify an epithelial cell subtype involved in breast cancer.
Gardner HP; Ha SI; Reynolds C; Chodosh LA
Cancer Res; 2000 Oct; 60(19):5571-7. PubMed ID: 11034105
[TBL] [Abstract][Full Text] [Related]
10. Brca1 regulates in vitro differentiation of mammary epithelial cells.
Kubista M; Rosner M; Kubista E; Bernaschek G; Hengstschläger M
Oncogene; 2002 Jul; 21(31):4747-56. PubMed ID: 12101413
[TBL] [Abstract][Full Text] [Related]
11. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
Hollmann CA; Kittrell FS; Medina D; Butel JS
Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin expression in mammary gland development and tumorigenesis.
Rittling SR; Novick KE
Cell Growth Differ; 1997 Oct; 8(10):1061-9. PubMed ID: 9342184
[TBL] [Abstract][Full Text] [Related]
13. Differential keratin gene expression in developing, differentiating, preneoplastic, and neoplastic mouse mammary epithelium.
Smith GH; Mehrel T; Roop DR
Cell Growth Differ; 1990 Apr; 1(4):161-70. PubMed ID: 1707299
[TBL] [Abstract][Full Text] [Related]
14. Laminin-rich extracellular matrix association with mammary epithelial cells suppresses Brca1 expression.
O'Connell FC; Martin F
Cell Death Differ; 2000 Apr; 7(4):360-7. PubMed ID: 10773820
[TBL] [Abstract][Full Text] [Related]
15. Elevated high mobility group-I(Y) gene expression is associated with progressive transformation of mouse mammary epithelial cells.
Ram TG; Reeves R; Hosick HL
Cancer Res; 1993 Jun; 53(11):2655-60. PubMed ID: 8495429
[TBL] [Abstract][Full Text] [Related]
16. Overexpression and forced activation of stat5 in mammary gland of transgenic mice promotes cellular proliferation, enhances differentiation, and delays postlactational apoptosis.
Iavnilovitch E; Groner B; Barash I
Mol Cancer Res; 2002 Nov; 1(1):32-47. PubMed ID: 12496367
[TBL] [Abstract][Full Text] [Related]
17. Hyperplasia and impaired involution in the mammary gland of transgenic mice expressing human FGF4.
Morini M; Astigiano S; Mora M; Ricotta C; Ferrari N; Mantero S; Levi G; Rossini M; Barbieri O
Oncogene; 2000 Dec; 19(52):6007-14. PubMed ID: 11146552
[TBL] [Abstract][Full Text] [Related]
18. c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer.
Regan JL; Kendrick H; Magnay FA; Vafaizadeh V; Groner B; Smalley MJ
Oncogene; 2012 Feb; 31(7):869-83. PubMed ID: 21765473
[TBL] [Abstract][Full Text] [Related]
19. Mice heterozygous for a Brca1 or Brca2 mutation display distinct mammary gland and ovarian phenotypes in response to diethylstilbestrol.
Bennett LM; McAllister KA; Malphurs J; Ward T; Collins NK; Seely JC; Gowen LC; Koller BH; Davis BJ; Wiseman RW
Cancer Res; 2000 Jul; 60(13):3461-9. PubMed ID: 10910057
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis in normal and neoplastic mammary gland development.
Strange R; Metcalfe T; Thackray L; Dang M
Microsc Res Tech; 2001 Jan; 52(2):171-81. PubMed ID: 11169865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
